Research Projects
The research in our group is focused on advanced drug delivery strategies for enhanced bioavailability of poorly absorbable drugs as well as selective drug delivery for a variety of pathologies. This includes formulation design not only for small molecules, but also peptides and proteins and their biopharmaceutical evaluation in-vitro and in-vivo in relevant cell culture or animal models. In order to permit a successful delivery a strong interest consists in the smart design of such drug delivery systems, among them micro- and nanoparticles, micro-emulsions, self-emulsifying systems, and liposomes. One further aspect are the related preparation techniques in view of a potential scale-up.
Oral drug delivery
- Enhanced bioavailability of drugs
- selective targeting to inflamed intestinal tissue
Drug delivery to the skin
- Enhanced bioavailability of drugs
- selective drug delivery to inflamed skin
Delivery to the lungs and nose
- Enhanced bioavailability of drugs after nasal administration
- Enhanced drug delivery into the deep lung
Drug delivery to the blood-brain-barrier
With the help of newly developed ex-vivo tissue model we aim for understanding drug transport mechanisms at the BBB and the related consequences for the design of efficient delivery strategies across the BBB
Immune therapy in cancer
Controlled release of peptides and proteins
Design of biodegradable implants for sustained release of small molecules, peptides and proteins, including microspheres, monolithic implants as well as in-situ forming systems, biorelevant in-vitro test systems for the design of implants